CTF1 and Insulin resistance: Moreover, recombinant CT-1 treatment corrected insulin resistance and reduced adiposity in ob/ob and high-fat diet (HFD) receiving mice, pointing to a key regulatory role of CT-1 in glucose and lipid metabolism [6].